{
    "clinical_study": {
        "@rank": "117487", 
        "arm_group": [
            {
                "arm_group_label": "59 mL noni juice", 
                "arm_group_type": "Experimental", 
                "description": "Ingestion of 59 mL of Tahitian Noni\u00ae juice (mixture of noni juice and grape and blueberry juices) twice daily (118 mL daily total) for 30 days."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Ingestion of 59 mL of placebo (mixture of grape and blueberry juices and natural cheese flavor) twice daily (118 mL daily total) for 30 days."
            }, 
            {
                "arm_group_label": "29.5 mL noni dose", 
                "arm_group_type": "Experimental", 
                "description": "Ingestion of 29.5 mL of Tahitian Noni\u00ae juice (mixture of noni juice and grape and blueberry juices) daily for 30 days."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study was to determine if noni juice reduces lipid hydroperoxide (LOOH)\n      and malondialdehyde (MDA) derived-DNA adducts, markers of oxidative DNA damage, in\n      peripheral blood lymphocytes of cigarette smokers."
        }, 
        "brief_title": "Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Heavy Smokers", 
        "completion_date": {
            "#text": "August 2006", 
            "@type": "Actual"
        }, 
        "condition": "Oxidative Damage of DNA Due to Cigarette Smoking.", 
        "condition_browse": {
            "mesh_term": "Smoking"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 to 65 years in age, smoker of more than 20 cigarettes per day, a smoking history\n             exceeding one year, and willing to complete a one month trial.\n\n        Exclusion Criteria:\n\n          -  concurrent use, or use in the previous three months, of prescription medication or\n             antioxidant vitamins"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "317", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01677169", 
            "org_study_id": "TNI-UIC-01"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "59 mL noni juice", 
                    "29.5 mL noni dose"
                ], 
                "description": "Ingestion of noni juice, a source of iridoids, daily for 30 days.", 
                "intervention_name": "Noni juice", 
                "intervention_type": "Dietary Supplement", 
                "other_name": [
                    "Tahitian Noni\u00ae Juice", 
                    "Tahitian Noni\u00ae Original Bioactive", 
                    "Thrive Adaptogenics Original"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 30, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rockford", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "61107"
                }, 
                "name": "University of Illinois College of Medicine at Rockford"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Double Blind, Randomized, Placebo-controlled Clinical Trial of the Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Current Heavy Smokers", 
        "overall_official": {
            "affiliation": "University of Illinois at Chicago", 
            "last_name": "Mian-ying Wang, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2005", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "LOOH and MDA-DNA adducts in lymphocytes immediately prior to intervention and at completion of intervention.", 
            "measure": "LOOH and MDA-DNA adducts", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01677169"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Adverse health events", 
            "measure": "adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "source": "Tahitian Noni International, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Illinois at Chicago", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Tahitian Noni International, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2000", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}